These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9827926)

  • 1. Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia.
    Elliott MA; Chen MG; Silverstein MN; Tefferi A
    Br J Haematol; 1998 Nov; 103(2):505-11. PubMed ID: 9827926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenic irradiation provides transient palliation for symptomatic splenomegaly associated with primary myelofibrosis: a report on 14 patients.
    Kitanaka A; Takenaka K; Shide K; Miyamoto T; Kondo T; Ozawa K; Kurokawa M; Akashi K; Shimoda K
    Int J Hematol; 2016 Apr; 103(4):423-8. PubMed ID: 26791378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative irradiation of the spleen.
    McFarland JT; Kuzma C; Millard FE; Johnstone PA
    Am J Clin Oncol; 2003 Apr; 26(2):178-83. PubMed ID: 12714892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review.
    Elliott MA; Tefferi A
    Blood Rev; 1999 Sep; 13(3):163-70. PubMed ID: 10527268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy for symptomatic hepatomegaly in myelofibrosis with myeloid metaplasia.
    Tefferi A; Jiménez T; Gray LA; Mesa RA; Chen MG
    Eur J Haematol; 2001 Jan; 66(1):37-42. PubMed ID: 11168506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic irradiation as palliative treatment for symptomatic splenomegaly due to secondary myelofibrosis: a multi-institutional experience.
    Pistevou-Gombaki K; Zygogianni A; Kantzou I; Kyrgias G; Mystakidou K; Kouvaris J; Klonizakis I; Tsirigotis P; Pappa V; Siakantari M; Eleftheriadis N; Georgakopoulos J; Sarris G; Kelekis N; Kouloulias V
    J BUON; 2015; 20(4):1132-6. PubMed ID: 26416067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive splenic radiotherapy for symptomatic splenomegaly management in myeloproliferative disorders.
    Sager O; Beyzadeoglu M; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Akin M; Gundem E; Dirican B
    Tumori; 2015; 101(1):84-90. PubMed ID: 25702680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks and benefits of splenectomy in myelofibrosis with myeloid metaplasia: a retrospective analysis of 26 cases.
    Akpek G; McAneny D; Weintraub L
    J Surg Oncol; 2001 May; 77(1):42-8. PubMed ID: 11344482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative splenectomy in myelofibrosis with myeloid metaplasia.
    Mesa RA; Tefferi A
    Leuk Lymphoma; 2001; 42(5):901-11. PubMed ID: 11697645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
    Petroianu A
    Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma.
    Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Abe O; Saito T; Tanaka Y
    Hematology; 2015 May; 20(4):203-7. PubMed ID: 25131182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic irradiation for splenomegaly: A systematic review.
    Zaorsky NG; Williams GR; Barta SK; Esnaola NF; Kropf PL; Hayes SB; Meyer JE
    Cancer Treat Rev; 2017 Feb; 53():47-52. PubMed ID: 28063304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Pharmacologic Management of Splenomegaly for Patients with Myelofibrosis: Is There Any Role for Splenectomy or Splenic Radiation in 2020?
    Sankar K; Pettit K
    Curr Hematol Malig Rep; 2020 Oct; 15(5):391-400. PubMed ID: 32827272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia. Results of daily and intermittent fractionation with and without concomitant hydroxyurea.
    Wagner H; McKeough PG; Desforges J; Madoc-Jones H
    Cancer; 1986 Sep; 58(6):1204-7. PubMed ID: 2427184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Symptomatic irradiation therapy of the spleen in advanced osteomyelosclerosis].
    Slanina J; Vondraczek A; Wannenmacher M
    Dtsch Med Wochenschr; 1986 Jul; 111(30):1144-50. PubMed ID: 2426078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy for splenomegaly.
    Mod H; Prasiko G; Jha AK; Chaurasia PP; Srivastava R
    JNMA J Nepal Med Assoc; 2005; 44(159):97-9. PubMed ID: 16554863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Splenic irradiation in the treatment of idiopathic myelofibrosis. Retrospective study of 14 cases].
    Sciascia R; Mazza P; Tondi L
    Radiol Med; 1988; 76(1-2):87-90. PubMed ID: 3399713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenectomy in myeloid metaplasia.
    Cabot EB; Brennan MF; Rosenthal DS; Wilson RE
    Ann Surg; 1978 Jan; 187(1):24-30. PubMed ID: 74243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.
    Tefferi A; Mesa RA; Nagorney DM; Schroeder G; Silverstein MN
    Blood; 2000 Apr; 95(7):2226-33. PubMed ID: 10733489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of splenic irradiation in chronic lymphocytic leukemia.
    Guiney MJ; Liew KH; Quong GG; Cooper IA
    Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):225-9. PubMed ID: 2912945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.